Real-time enrollment status for this severe asthma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT03953300 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Severe Asthma |
| Phase | Clinical Trial |
| Target Enrollment | 81 participants |
| Active Locations | 34 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT03953300 is currently active_not_recruiting participants. This clinical trial study for severe asthma is not currently accepting new participants at 34 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03953300 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03953300 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.